Dent Neurologic Institute

Summary

Dent Neurologic Institute is a medical facility located in Buffalo, New York. This center is recognized for care of Migraine, Vestibular Migraine, Alzheimer's Disease, Headache, Epilepsy and other specialties. Dent Neurologic Institute is involved with conducting 131 clinical trials across 118 conditions. There are 10 research doctors associated with this hospital, such as Laszlo Mechtler, Horacio Capote, MD, Bela Ajtai, and Jennifer McVige, MD.

Top PIs

Clinical Trials running at Dent Neurologic Institute

Migraine

Vestibular Migraine

Epilepsy

Alzheimer's Disease

Headache

Obesity

Hyperacusis

Photophobia

Nausea and Vomiting

Peripheral Neuropathy

Eptinezumab

for Migraine

The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).

Recruiting

3 awards

Phase 4

2 criteria

Rimegepant

for Pediatric Migraine

This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.

Recruiting

2 awards

Phase 3

8 criteria

Galcanezumab

for Migraine

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.

Recruiting

1 award

Phase 3

1 criteria